DuPont Enhances Medical Device Expertise Through Donatelle Acquisition

On June 25, 2024, DuPont (NYSE: DD) revealed its agreement to purchase Donatelle Plastics Incorporated, a prominent contract manufacturer in the medical device sector known for designing, developing, and producing medical components and devices. The transaction is anticipated to conclude in the third quarter of 2024, pending fulfillment of standard closing conditions and regulatory approvals.

"Our healthcare strategy aims to provide a complete range of solutions tailored to high-growth therapeutic sectors," stated Jon Kemp, President of DuPont Electronics & Industrial (E&I). " Adding Donatelle Plastics Incorporated to our portfolio, following our acquisition of Spectrum last year, will enhance our expertise in medical device market segments and solidify our standing as a trusted partner for our customers."

Within DuPont's Industrial Solutions division of the E&I segment, the healthcare portfolio encompasses Spectrum, a leader in medical device components, and Liveo™, renowned for silicone solutions in healthcare applications. The acquisition of Donatelle Plastics Incorporated will introduce complementary advanced technologies and capabilities, spanning medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool manufacturing. Donatelle Plastics Incorporated boasts a robust financial growth trajectory aligned with promising therapeutic sectors such as electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.

Established in 1967 and based in New Brighton, Minnesota, Donatelle Plastics Incorporated employs over 400 professionals and operates a facility strategically positioned within a hub of medical technology near prominent original equipment manufacturers. Over the years, Donatelle has built enduring partnerships through superior customer service, exceptional quality, and expertise in injection molding. The company is renowned for its innovative approach to manufacturing medical devices and components, particularly in demanding applications that necessitate high standards of quality, reliability, and technical proficiency.

"We're looking forward to the next phase of Donatelle's evolution and for our team of exceptionally talented employees to become part of DuPont," expressed Treasa Springett, President of Donatelle Plastics Incorporated. "Within our expansive healthcare portfolio, we expect to profoundly influence patient outcomes by fostering innovation and advancing next-generation devices for patients worldwide."

DuPont (NYSE: DD) is a leading innovator globally, offering technology-driven materials and solutions that drive transformation across industries and daily life. Our diverse team of experts applies scientific knowledge to support customers in advancing their most promising ideas and delivering crucial innovations in vital sectors such as electronics, transportation, construction, water management, healthcare, and worker safety. DuPont creates vital innovations that are crucial for today's world.